Dr. Scharles Konadu Joins TDDC in Fort Worth
April 24, 2024 08:40 ET
|
GI Alliance
Fort Worth, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Texas Digestive Disease Consultants is excited to welcome Dr. Scharles Konadu, a multi-talented rising star in the gastroenterology field who...
GI Alliance of Illinois Moves to Upgraded Facility
April 17, 2024 08:35 ET
|
GI Alliance
EVANSTON, IL, April 17, 2024 (GLOBE NEWSWIRE) -- GI Alliance of Illinois, a local gastroenterology practice that offers cutting-edge treatment in Evanston, IL, has moved to a new gastro clinic,...
2nd Annual Butts & Guts 5K Presented by Giant Leap Foundation
April 15, 2024 07:35 ET
|
GI Alliance
New Orleans, LA, April 15, 2024 (GLOBE NEWSWIRE) -- Giant Leap Foundation - a non-profit organization dedicated to promoting health and wellness initiatives in communities across the nation - is...
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
April 10, 2024 11:48 ET
|
University, Cancer and Blood Center
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs.
Arizona Digestive Health Expands Into Tucson
April 10, 2024 10:35 ET
|
GI Alliance
TUCSON, Arizona, April 10, 2024 (GLOBE NEWSWIRE) -- Arizona Digestive Health, the premier gastroenterology practice in Arizona, has opened a new gastro clinic and an endoscopy center, both located...
US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
April 05, 2024 09:17 ET
|
Spherix Global Insights
EXTON, PA, April 05, 2024 (GLOBE NEWSWIRE) -- As the first treatment to gain FDA approval for metabolic dysfunction-associated steatohepatitis (MASH), Madrigal Pharmaceuticals’ Rezdiffra...
Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous formulation of Entyvio for the Treatment of Ulcerative Colitis, but Future Projections Reveal a Highly Evolving Market
March 22, 2024 10:14 ET
|
Spherix Global Insights
Exton, Pennsylvania, March 22, 2024 (GLOBE NEWSWIRE) -- The end of 2023 introduced several new treatment options for patients suffering from ulcerative colitis (UC). Among them is Eli Lilly’s Omvoh...
Sosei Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease
March 20, 2024 20:05 ET
|
Sosei Group Corporation
HTL0033744 has been designed by Sosei Heptares to promote mucosal healing and resolve inflammation in people with IBD Tokyo, Japan and Cambridge, UK, 21 March 2024 – Sosei Group Corporation (“Sosei...
Feeding Tubes Market Size to Surpass Around US$ 9.69 Billion 2030, Recording a CAGR of 6.2% | Report by CoherentMI
March 20, 2024 06:21 ET
|
CMI
Burlingame, March 20, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, Feeding Tubes Market was valued at US$ 6.34 Billion in the year 2023 and is anticipated to reach US$ 9.69...
Short Bowel Syndrome (SBS) Market Projected to Surge to $5.7 Billion Globally by 2030, with High CAGR in GLP-2 and Growth Hormone Segments
March 06, 2024 10:24 ET
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Short Bowel Syndrome (SBS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global Short Bowel...